DE69937580D1 - Agent zur induktion einer immunologischen toleranz - Google Patents
Agent zur induktion einer immunologischen toleranzInfo
- Publication number
- DE69937580D1 DE69937580D1 DE69937580T DE69937580T DE69937580D1 DE 69937580 D1 DE69937580 D1 DE 69937580D1 DE 69937580 T DE69937580 T DE 69937580T DE 69937580 T DE69937580 T DE 69937580T DE 69937580 D1 DE69937580 D1 DE 69937580D1
- Authority
- DE
- Germany
- Prior art keywords
- inducing
- agent
- immunological tolerance
- autoimmune diseases
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Marine Sciences & Fisheries (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/KR1999/000460 WO2001012222A1 (en) | 1999-08-18 | 1999-08-18 | Immunological tolerance-induction agent |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69937580D1 true DE69937580D1 (de) | 2007-12-27 |
Family
ID=19570981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69937580T Expired - Lifetime DE69937580D1 (de) | 1999-08-18 | 1999-08-18 | Agent zur induktion einer immunologischen toleranz |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1212086B8 (de) |
JP (1) | JP3926626B2 (de) |
AT (1) | ATE378067T1 (de) |
AU (1) | AU5307899A (de) |
DE (1) | DE69937580D1 (de) |
WO (1) | WO2001012222A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005527553A (ja) * | 2002-03-29 | 2005-09-15 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 自己免疫疾患の治療におけるスタチン類および他の自己免疫調節剤の利用 |
JP5271475B2 (ja) | 2002-11-26 | 2013-08-21 | ザ ユニヴァーシティー オヴ シカゴ | 微生物媒介上皮疾患の予防及び治療のための材料並びに方法 |
JP2008297204A (ja) * | 2007-05-29 | 2008-12-11 | Masahiro Murakami | ポリ乳酸混合物を含む肝繊維化の抑制又は改善剤 |
DE102007039446A1 (de) | 2007-08-21 | 2009-02-26 | Volkswagen Ag | Verfahren zum Anzeigen von Informationen in einem Kraftfahrzeug mit veränderbarem Maßstab und Anzeigeeinrichtung |
US11041013B2 (en) | 2008-03-14 | 2021-06-22 | Cel-Sci Corporation | Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis |
GB2485327A (en) * | 2009-08-12 | 2012-05-09 | Sigmoid Pharma Ltd | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
KR101908445B1 (ko) | 2010-11-12 | 2018-10-17 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. | 변형된 면역-조절 입자 |
WO2012162564A1 (en) | 2011-05-25 | 2012-11-29 | Cel-Sci Corporation | Method for inducing an immune response and formulations thereof |
RU2669346C2 (ru) | 2012-06-21 | 2018-10-10 | Норсвестерн Юниверсити | Частицы, конъюгированные с пептидами |
IL292823B2 (en) | 2013-03-13 | 2023-11-01 | Cour Pharmaceuticals Dev Company | Secondary vaccine particles for the treatment of inflammation |
DK3033102T4 (da) * | 2013-08-13 | 2024-02-26 | Univ Northwestern | Peptidkonjugerede partikler |
CN111109198B (zh) * | 2019-03-29 | 2021-08-20 | 成都华西海圻医药科技有限公司 | 一种葡萄膜炎动物模型构建方法 |
CA3140649A1 (en) * | 2019-05-16 | 2020-11-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Metabolite delivery for modulating metabolic pathways of cells |
US20220280557A1 (en) * | 2019-09-12 | 2022-09-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Metabolic Reprogramming of Immune Cells for the Treatment or Prevention of Diseases and Disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69334246D1 (de) * | 1992-12-03 | 2008-12-24 | Univ California | Verbesserte reagentien und methoden zur diagnose und behandlung von diabetes und stiff man syndrome |
IS4518A (is) * | 1997-07-09 | 1999-01-10 | Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group | Nýtt lyfjaform fyrir bóluefni |
US6312731B1 (en) * | 1997-08-29 | 2001-11-06 | Southern Research Institute | Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof |
WO1999037315A1 (en) * | 1998-01-27 | 1999-07-29 | Bai Jane Pei Fan | Chemical derivatives of autoantigens and autoimmune-suppressive peptides and pharmaceutical composition containing the same |
-
1999
- 1999-08-18 AU AU53078/99A patent/AU5307899A/en not_active Abandoned
- 1999-08-18 AT AT99938639T patent/ATE378067T1/de not_active IP Right Cessation
- 1999-08-18 WO PCT/KR1999/000460 patent/WO2001012222A1/en active IP Right Grant
- 1999-08-18 EP EP99938639A patent/EP1212086B8/de not_active Expired - Lifetime
- 1999-08-18 DE DE69937580T patent/DE69937580D1/de not_active Expired - Lifetime
- 1999-08-18 JP JP2001516567A patent/JP3926626B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3926626B2 (ja) | 2007-06-06 |
EP1212086A1 (de) | 2002-06-12 |
EP1212086B1 (de) | 2007-11-14 |
AU5307899A (en) | 2001-03-13 |
WO2001012222A1 (en) | 2001-02-22 |
ATE378067T1 (de) | 2007-11-15 |
JP2003507340A (ja) | 2003-02-25 |
EP1212086B8 (de) | 2008-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69937580D1 (de) | Agent zur induktion einer immunologischen toleranz | |
WO2001085154A3 (en) | Method of treating immune pathologies with low dose estrogen | |
WO1999064059A3 (en) | Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders | |
NO963280L (no) | Anvendelse av anti-TNF antistoffer som legemidler i behandling av sykdommer som involverer forhöyede interleukin-6 serumnivåer | |
BR9814393A (pt) | Micropartìculas e uso terapêutico ou diagnóstico delas | |
ATE237330T1 (de) | Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung | |
ATE376832T1 (de) | Verzögert freisetzende formulierungen von oxymorphon | |
DE69605184T2 (de) | Verabreichung einer substanz in den mund | |
TR200001982T2 (tr) | Farmasötik vurulu salınımlı oral dozaj şekli. | |
SI1270595T1 (sl) | Protitelo proti CCR4 in njegov fragment | |
DE69936393D1 (de) | Behandlung akuter gesundheitsstörungen durch die sublingual verabreichung einer pharmazeutischen zusammensetzung | |
EE04606B1 (et) | H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks | |
SE9602931D0 (sv) | New medicinal use | |
IT1319275B1 (it) | Uso del baclofen nel trattamento dell'astinenza da etanolo. | |
BG106226A (en) | A blocking monoclinal antibody to vla-1 and its use for the treatment of inflammatory disorders | |
ES2099747T3 (es) | Aplicacion topica terapeuticamente eficaz de la st1435. | |
PT862454E (pt) | Novas utilizacoes de ctla-8 de mamifero e reagentes relacionados | |
NO20030985D0 (no) | Behandling av betennelsestilstander | |
DK1231908T3 (da) | Farmaceutisk præparat, der omfatter en NO-donorforbindelse samt anvendelse heraf | |
WO1997035884A8 (en) | Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies | |
Tse et al. | Chronic bullous dermatosis of childhood: Differentiation from other autoimmune blistering diseases in children | |
SE9700617D0 (sv) | New composition | |
IL163431A (en) | 1 - phenyl - 2 - heteroaryl - substituted benzimidazole derivatives and the use thereof for producing drugs used in the treatment of immunological diseases | |
RU98112055A (ru) | Способ лечения заболеваний слизистой оболочки рта у больных с вторичными иммунодефицитами | |
WO2002028430A3 (en) | Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |